RESOLVE THERAPEUTICS

resolve-therapeutics-logo

Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus. They are focused on the advancement their exciting, novel biologic compound, RSLV-125 from preclinical research through a phase IIa clinical trial. The company is based on the pioneering discoveries made by Dr. Keith Elkon and Dr. Jeff Ledbetter in their laboratories at the University of Washington School of Medicine.

#People #Financial #Website #More

RESOLVE THERAPEUTICS

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2010-01-01

Address:
Kirkland, Washington, United States

Country:
United States

Website Url:
http://www.resolvebio.com

Total Employee:
1+

Status:
Active

Contact:
425-576-4100

Total Funding:
8.88 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Google Google Cloud



Current Advisors List

peter-kiener_image

Peter Kiener Board of Managers @ Resolve Therapeutics
Board_member

thong-le_image

Thong Le Board Observer @ Resolve Therapeutics
Board_observer

Current Employees Featured

not_available_image

Raj Dua
Raj Dua Managing the CMC @ Resolve Therapeutics
Managing the CMC

james-posada_image

James Posada
James Posada Co-Founder and CEO @ Resolve Therapeutics
Co-Founder and CEO
2010-04-01

Founder


james-posada_image

James Posada

Investors List

new-science-ventures_image

New Science Ventures

New Science Ventures investment in Series B - Resolve Therapeutics

washington-research-foundation_image

Washington Research Foundation

Washington Research Foundation investment in Series B - Resolve Therapeutics

easton-capital_image

Easton Capital

Easton Capital investment in Series B - Resolve Therapeutics

new-science-ventures_image

New Science Ventures

New Science Ventures investment in Series A - Resolve Therapeutics

easton-capital_image

Easton Capital

Easton Capital investment in Series A - Resolve Therapeutics

Official Site Inspections

http://www.resolvebio.com

  • Host name: a16e665f42988324c.awsglobalaccelerator.com
  • IP address: 13.248.243.5
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Resolve Therapeutics"

Resolve Biosciences

Mar 15, 2023 Â· Our Molecular Cartography platform is a groundbreaking multi-analyte, highly multiplex spatial analysis technology that enables scientists to resolve the most complex …See details»

Meet – Resolve Biosciences

Resolve Biosciences is privately held and headquartered in Monheim am Rhein, Germany. The $24 million Series A financing round was led by PS Capital Management and MasterMind …See details»

Resolve BioSciences - Crunchbase Company Profile

Resolve Biosciences is a biotechnology research company for molecular cartography. View contacts for Resolve BioSciences to access new leads and connect with decision-makers.See details»

Resolution Bioscience

Longitudinal monitoring offers the ability to monitor tumor evolution over time and under treatment. Allelic frequencies can change quickly. At disease progression, it becomes critical to have a …See details»

Resolve Biosciences Launches Commercial Molecular …

Jun 2, 2021 Â· MONHEIM AM RHEIN, Germany, and SAN JOSE, Calif. – June 2, 2021 – Resolve Biosciences today announced the commercial launch of its groundbreaking Molecular …See details»

Resolve Biosciences - LinkedIn

Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology.See details»

Resolve BioSciences - Welcome!

Here, we provide access for registered customers to design panels, manage service projects, and analyze and visualize data. Please check our main website for information about our company, …See details»

Resolution Bioscience - LinkedIn

Resolution Bioscience, a part of Agilent, is pioneering next generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy.See details»

Resolve Biosciences Secures $71 Million Series B Financing to ...

Oct 24, 2022 Â· Resolve Biosciences is applying the power of Molecular Cartographyâ„¢ to enable scientists to gain new insights based on the highest-resolution view of spatial biology.See details»

Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis

Dec 10, 2020 Â· Resolve Biosciences announces $24 million Series A financing and appoints Jason T. Gammack as CEO to accelerate development and commercialization of Molecular …See details»

Resolve Biosciences Sets New Standard for Single-Cell Spatial …

Aug 10, 2022 Â· MONHEIM AM RHEIN, Germany – June 7, 2022 – Resolve Biosciences, the pioneer in Molecular Cartography TM, today announced the launch of its commercial …See details»

Resolve biosciences and ZEISS announce co-development …

Aug 3, 2021 Â· Resolve Biosciences, the pioneer in Molecular Cartographyâ„¢, and ZEISS today announced a co-development collaboration to advance spatial biology applications. The …See details»

Resolve Biosciences (@ResolveBioSci) / X

The latest posts from @ResolveBioSciSee details»

RESOLVE

Leader of the Kuyendoya farmer-based organization, a mini-agricultural cooperative. At RESOLVE, we’re here to tackle the toughest global challenges. The ones nobody else wants …See details»

Resolve Therapeutics Publishes Positive Sjogren’s Syndrome …

St. Petersburg, FL – December 3, 2020 – Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced publication …See details»

Press releases – Resolve Biosciences

Feb 21, 2021 Â· Life sciences tools veteran brings decades of experience leading successful teams, commercializing industry-defining technology platforms, and scaling global organizations.See details»

Resolve Therapeutics publishes positive Sjogren's syndrome …

Dec 3, 2020 Â· Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced publication of results from its Phase 2 …See details»

Resolve Therapeutics Announces Completion of Enrollment for …

Jul 22, 2019 Â· Resolve Therapeutics is pioneering safe, targeted therapies for underserved autoimmune diseases with large unmet medical need. The Company’s lead compound, RSLV …See details»

Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis

Dec 10, 2020 Â· Company announces $24 million Series A financing and appoints Jason T. Gammack as CEO to accelerate development and commercialization of Molecular …See details»

Spatial biology – Resolve Biosciences

Scientists have been aware that spatial context matters in biology. Long before they had the technology to provide detailed data, there was an acceptance that biological …See details»

linkstock.net © 2022. All rights reserved